ECTRIMS 2024: Adult Dose of Ocrelizumab Safe, Effective for Pediatric-Onset Multiple Sclerosis
No new safety signals seen for children, adolescents with body weight >35 kg
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.